Belgium

BMI View: Belgium's ageing population will have an unprecedented effect on the demand for pharmaceuticals and healthcare, which is a positive for companies operating in the industry.... 2012-01-25

BMI View: The expected growth of Belgium's ageing population is to have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than... 2011-07-26

BMI Core View: The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development process, as the value of... 2011-06-02

BMI View: In BMI's Business Environment Ratings for Q211, Belgium scored 64.5 out of a total of 100 in BMI's, placing it fifth in the western Europe matrix. Although growth in medicine... 2011-02-01

BMI View: While Belgium is not a major hub for research and development (R&D) compared with some of its European neighbours, we believe the country is establishing itself as a centre... 2010-12-17

Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer... 2010-09-28

Multinational drugmaker Shire is to acquire Belgian drugmaker Movetis for EUR428mn (US$565mn), or EUR19 a share - a 60% premium on their earlier price of EUR11.90 - funded by the company's... 2010-08-05

As of April 2010, pharmacists in Belgium receive a fixed reimbursement amount of EUR3.88 plus VAT for every pack of medicines sold. This new system replaces the old proportional reimbursement... 2010-05-24

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15

In February 2010, the Belgian Association of Clinical Research Professionals (ACRP.be), the Belgian Association of Pharmaceutical Physicians (BeAPP), the Belgian Association of Phase... 2010-03-02